SARS-CoV-2 evolution during treatment of chronic infection
Steven A. Kemp(Africa Health Research Institute), Benjamin J. Dunmore(University College London), Jo Calder(Cambridge University Hospitals NHS Foundation Trust), Chloe Rees-Spear(University of London), Valentina Ruffolo(University of Cambridge), Jane Rowlands(Cambridge University Hospitals NHS Foundation Trust), Christoph Hess(University of Cambridge), Michael P. Weekes(University of Cambridge), Stewart Fuller(Cambridge University Hospitals NHS Foundation Trust), Cherry Publico(Cambridge University Hospitals NHS Foundation Trust), Nathalie Kingston, Stephen Baker(University of Connecticut), Hugo Tordesillas(Cambridge University Hospitals NHS Foundation Trust), Charlotte Summers(Queen Mary University of London), Caroline Saunders(Cambridge University Hospitals NHS Foundation Trust), James Thaventhiran(University of Cambridge), Mark Toshner, Rawlings Datir(University of Cambridge), Jane Kennet(Cambridge University Hospitals NHS Foundation Trust), Paul Lyons(Cambridge School), Ben Bullman(University of Cambridge), Carla M. S. Ribeiro(Netherlands Center for Occupational Diseases), Dami A. Collier(University of Cambridge), Anita Chandra(University of Cambridge), Willem H. Owehand(University of Cambridge), Ashlea Bucke(Cambridge University Hospitals NHS Foundation Trust), Jason Domingo(Cambridge University Hospitals NHS Foundation Trust), Petra Mlčochová(e-Therapeutics (United Kingdom)), Sarah Hewitt(Cambridge University Hospitals NHS Foundation Trust), Myra Hosmillo(University of Cambridge), Nigel Temperton(Medway School of Pharmacy), Jenny Kourampa(Cambridge University Hospitals NHS Foundation Trust), Paul J. Lehner(University of Cambridge), Rebecca Rastall(Cambridge University Hospitals NHS Foundation Trust), Ines Ushiro Lumb(NHS Blood and Transplant), Nicholas J. Matheson(NHS Blood and Transplant), Isabella A.T.M. Ferreira(University of Cambridge), Aminu S. Jahun(Department of Virology), Salma Gayed(Cambridge University Hospitals NHS Foundation Trust), Laura Canna(Cambridge University Hospitals NHS Foundation Trust), Julie Harris(Cambridge University Hospitals NHS Foundation Trust), Anne Meadows(Cambridge University Hospitals NHS Foundation Trust), Anne Elmer(Cambridge University Hospitals NHS Foundation Trust), Sherly Jose(Cambridge University Hospitals NHS Foundation Trust), Criona O’Brien(Cambridge University Hospitals NHS Foundation Trust), David J. Roberts(NHS Blood and Transplant), Gordon Dougan(University of Cambridge), Jane Price(Cambridge University Hospitals NHS Foundation Trust)
Cited by 1,088
Related Papers
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis
|The Lancet|2022|16k
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
|European Heart Journal|2022|3.6k
Postdischarge symptoms and rehabilitation needs in survivors of COVID‐19 infection: A cross‐sectional evaluation
|Journal of Medical Virology|2020|1.5k
SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion
|Nature|2021|1.4k